Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Diabetic cardiac autonomic neuropathy: insights from animal models.
Authors
Stables CL, Glasser RL, Feldman EL
Submitted By
Eva Feldman on 3/17/2014
Status
Published
Journal
Autonomic neuroscience : basic & clinical
Year
2013
Date Published
10/1/2013
Volume : Pages
177 : 74 - 80
PubMed Reference
23562143
Abstract
Cardiac autonomic neuropathy (CAN) is a relatively common and often devastating
complication of diabetes. The major clinical signs are tachycardia, exercise
intolerance, and orthostatic hypotension, but the most severe aspects of this
complication are high rates of cardiac events and mortality. One of the earliest
manifestations of CAN is reduced heart rate variability, and detection of this,
along with abnormal results in postural blood pressure testing and/or the
Valsalva maneuver, are central to diagnosis of the disease. The treatment
options for CAN, beyond glycemic control, are extremely limited and lack
evidence of efficacy. The underlying molecular mechanisms are also poorly
understood. Thus, CAN is associated with a poor prognosis and there is a
compelling need for research to understand, prevent, and reverse CAN. In this
review of the literature we examine the use and usefulness of animal models of
CAN in diabetes. Compared to other diabetic complications, the number of animal
studies of CAN is very low. The published studies range across a variety of
species, methods of inducing diabetes, and timescales examined, leading to high
variability in study outcomes. The lack of well-characterized animal models
makes it difficult to judge the relevance of these models to the human disease.
One major advantage of animal studies is the ability to probe underlying
molecular mechanisms, and the limited numbers of mechanistic studies conducted
to date are outlined. Thus, while animal models of CAN in diabetes are crucial
to better understanding and development of therapies, they are currently
under-used.
Investigators with authorship
Name
Institution
Eva Feldman
University of Michigan
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!